New brain cancer fight: adding Whole-Brain radiation to stop tumor return
NCT ID NCT03746080
Summary
This study tested whether adding whole-brain radiation therapy and a drug called plerixafor to the standard treatment could better control an aggressive type of brain tumor called glioblastoma (GBM). It involved 21 adults who had recently been diagnosed and had surgery. The main goal was to see if this combination could keep the cancer from getting worse for at least six months after starting treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford Cancer Institute Palo Alto
Palo Alto, California, 94304, United States
Conditions
Explore the condition pages connected to this study.